Camden Property Trust (CPT) Stock Forecast
Data as of Aug 1, 2026Real Estate · Current price $111.32 (-1.77%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Jan 20, 2026 | Michael Lewis | Truist Financial | $118.00 | +6.0% |
| Jan 13, 2026 | Richard Hightower | Barclays | $119.00 | +6.9% |
| Nov 25, 2025 | Richard Hightower | Barclays | $118.00 | +6.0% |
| Nov 10, 2025 | Richard Anderson | Cantor Fitzgerald | $105.00 | -5.7% |
| Aug 26, 2025 | Simon Yarmak | Stifel Nicolaus | $122.75 | +10.3% |
| Aug 14, 2025 | Nicholas Yulico | Scotiabank | $133.00 | +19.5% |
| Jul 15, 2025 | Richard Hightower | Barclays | $137.00 | +23.1% |
| May 19, 2025 | Michael Lewis | Truist Financial | $131.00 | +17.7% |
| Jan 1, 2025 | Linda Tsai | Jefferies | $117.00 | +5.1% |
| Nov 13, 2024 | Simon Yarmak | Stifel Nicolaus | $121.00 | +8.7% |
| Sep 10, 2024 | Omotayo Okusanya | Deutsche Bank | $115.00 | +3.3% |
| Sep 9, 2024 | Steve Sakwa | Evercore ISI | $116.00 | +4.2% |
| Sep 4, 2024 | Julien Blouin | Goldman Sachs | $139.00 | +24.9% |
| Aug 26, 2024 | Alexander Goldfarb | Piper Sandler | $128.00 | +15.0% |
| Aug 26, 2024 | James Feldman | Wells Fargo | $127.00 | +14.1% |
| Aug 23, 2024 | Michael Lewis | Truist Financial | $133.00 | +19.5% |
| Aug 12, 2024 | Jeffrey Spector | Bank of America Securities | $147.00 | +32.1% |
| Aug 5, 2024 | Brad Heffern | RBC Capital | $122.00 | +9.6% |
| May 30, 2024 | Vikram Malhotra | Mizuho Securities | $108.00 | -3.0% |
| May 28, 2024 | Amanda Sweitzer | Robert W. Baird | $115.00 | +3.3% |
Top Analysts Covering CPT
CPT vs Sector & Market
| Metric | CPT | Real Estate Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 3.05 | 2.60 | 2.42 |
| Analyst Count | 20 | 9 | 19 |
| Target Upside | +2.5% | +45.5% | +17.1% |
| P/E Ratio | 31.18 | 27.78 | 43.33 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $1.52B | $1.57B | $1.61B | 10 |
| 2027-03-31 | $388M | $398M | $411M | 4 |
| 2027-06-30 | $394M | $404M | $416M | 6 |
| 2027-09-30 | $398M | $407M | $420M | 4 |
| 2027-12-31 | $399M | $409M | $422M | 7 |
| 2028-03-31 | $394M | $404M | $417M | 3 |
| 2028-06-30 | $401M | $412M | $424M | 5 |
| 2028-09-30 | $408M | $418M | $431M | 3 |
| 2028-12-31 | $410M | $421M | $434M | 6 |
| 2029-12-31 | $1.70B | $1.75B | $1.82B | 2 |
| 2030-12-31 | $1.79B | $1.85B | $1.92B | 2 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $1.50 | $1.52 | $1.58 | 5 |
| 2027-03-31 | $0.29 | $0.30 | $0.31 | 1 |
| 2027-06-30 | $0.29 | $0.30 | $0.31 | 1 |
| 2027-09-30 | $0.30 | $0.31 | $0.32 | 1 |
| 2027-12-31 | $0.35 | $0.36 | $0.38 | 1 |
| 2028-03-31 | $0.51 | $0.53 | $0.55 | 1 |
| 2028-06-30 | $0.58 | $0.60 | $0.63 | 1 |
| 2028-09-30 | $0.58 | $0.60 | $0.62 | 1 |
| 2028-12-31 | $0.67 | $0.69 | $0.72 | 1 |
| 2029-12-31 | $2.03 | $2.12 | $2.23 | 1 |
| 2030-12-31 | $0.00 | $0.00 | $0.00 | 0 |
Frequently Asked Questions
What is the analyst consensus for CPT?
The consensus among 20 analysts covering Camden Property Trust (CPT) is Hold with an average price target of $112.16.
What is the highest price target for CPT?
The highest price target for CPT is $194.00, set by Alexander Goldfarb at Piper Sandler on 2023-10-31.
What is the lowest price target for CPT?
The lowest price target for CPT is $98.00, set by Richard Anderson at Wedbush on 2023-12-04.
How many analysts cover CPT?
20 analysts have issued ratings for Camden Property Trust in the past 12 months.
Is CPT a buy or sell right now?
Based on 20 analyst ratings, CPT has a consensus rating of Hold (3.05/5) with a +2.5% upside to the consensus target of $112.16.
What are the earnings estimates for CPT?
Analysts estimate CPT will report EPS of $1.52 for the period ending 2026-12-31, with revenue estimated at $1.57B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.